Holistech

Fed Targets Maker of Addiction Gene Test, Claiming Fraud

By Kristen Schepker, Assistant Editor

Earlier this month, federal agents took action against Proove Biosciences, the maker and marketer of an opioid addiction genetic test, alleging that company is perpetrating healthcare fraud. On June 7, agents from the US Attorney’s office in Southern California arrived at the headquarters of the Irvine-based company, whose Opioid Risk Profile is marketed as a […]

The Best of Medicine X 2016

By Erik Goldman, Editor in Chief

The annual Medicine X conference is a great place to learn about potentially transformative new medical technology. Here are a few that captured our attention this year.

Ph360: Can “Phenomics” Give Clues to Better Health?

By Madiha Saeed, MD, Contributing Writer

ph360 is a new algorithm for determining phenotypes and epigenetic profiles, and then figuring out custom-tailored exercise, and lifestyle plans. “The real key to our health is written in our body’s unique code. And we’ve cracked it,” says company founder Matt Riemann. HPC’s Dr. Madiha Saeed test-drives the system with her patients and shares her experience. 

Wearable Fitness Trackers: They’re Popular, But Are they Accurate?

By Leandro Pucci, Contributing Writer

Wearable fitness trackers are everywhere these days. Consumers are using them to monitor exercise, sleep, and a host of other health-related parameters. Sure, they’re popular, but are they reliable? Can we trust the numbers they give us? Leading researchers weigh in on that question.

Will FDA Start Regulating Fitness Trackers?

By Gina Cushenberry, Contributing Writer

Fitness and Health trackers hit the market strongly a few years ago, and they are evolving far faster than the federal regulatory framework for health-related products. Are they “medical devices” or “general wellness products?” FDA’s recent draft guidance provides clues to the futurre regulation of these popular products.